Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gypenoside LXXV, derived from Gynostemma pentaphyllum, is a deglycosylated form of ginsenoside Rb1. This compound effectively decreases cancer cell viability and exhibits potent anti-cancer properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | Inquiry | $ 782.00 |
Description | Gypenoside LXXV, derived from Gynostemma pentaphyllum, is a deglycosylated form of ginsenoside Rb1. This compound effectively decreases cancer cell viability and exhibits potent anti-cancer properties. |
In vitro | Gypenoside LXXV administered at concentrations ranging from 1.0 to 100 μM for 48 hours effectively decreases cell proliferation in a dose-dependent manner across three cancer cell lines: HeLa (cervical cancer), B16 (melanoma), and MDA-MB231 (human breast cancer). A concentration of 50 μM was notably effective, significantly reducing proliferation and nearly inhibiting all targeted cancer cells[1]. |
Molecular Weight | 785.025 |
Formula | C42H72O13 |
CAS No. | 110261-98-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gypenoside LXXV 110261-98-8 inhibitor inhibit